Linkage and retention in care and the time to HIV viral suppression and viral rebound – New York City

References

• Attia, S., Egger, M., Muller, M., Zwahlen, M., & Low, N. (2009). Sexual transmission of HIV according to viral load and antiretroviral therapy: Systematic review and meta-analysis. AIDS, 23, 1397–1404. doi:10.1097/QAD.0b013e32832b7dca
   PubMed Web of Science ®Google Scholar
• Bunnell, R., Ekwaru, J. P., Solberg, P., Wamai, N., Bikaako-Kajura, W., Were, W., … Mermin, J. (2006). Changes in sexual behavior and risk of HIV transmission after antiretroviral therapy and prevention interventions in rural Uganda. AIDS, 20(1), 85–92. doi:10.1097/01.aids.0000196566.40702.28
   PubMed Web of Science ®Google Scholar
• Buskin, S. E., Barash, E. A., Bauer, A. L., Kent, J. B., Garcia-Smith, H. R., & Wood, R. W. (2011). HIV infected individuals presumed to not be receiving HIV medical care: A surveillance program evaluation for investigations and referrals in Seattle, WA. Journal of HIV/AIDS Surveillance & Epidemiology, 3(1), 3.
   Google Scholar
• Cohen, M. S., Chen, Y. Q., McCauley, M., Gamble, T., Hosseinipour, M. C., Kumarasamy, N., … Fleming, T. R. (2011). Prevention of HIV-1 infection with early antiretroviral therapy. New England Journal of Medicine, 365, 493–505. doi:10.1056/NEJMoa1105243
   PubMed Web of Science ®Google Scholar
• Das, M., Chu, P. L., Santos, G.-M., Scheer, S., Vittinghoff, E., McFarland, W., & Colfax, G. N. (2010). Decreases in community viral load are accompanied by reductions in new HIV infections in San Francisco. PLoS One, 5(6), e11068. doi:10.1371/journal.pone.0011068.t001
   PubMed Web of Science ®Google Scholar
• Department of Health and Human Services. (2005). Guidelines for the use of antiretroviral agents in HIV-1-infected adults and adolescents. Retrieved January 2, 2013, from http://aidsinfo.nih.gov/ContentFiles/AdultandAdolescentGL04072005001.pdf
   Google Scholar
• Department of Health and Human Services. (2012). Guidelines for the use of antiretroviral agents in HIV-1-infected adults and adolescents. Retrieved September 10, 2012, from http://aidsinfo.nih.gov/guidelines
   Google Scholar
• Dombrowski, J. C., Kent, J. B., Buskin, S. E., Stekler, J. D., & Golden, M. R. (2012). Population-based metrics for the timing of HIV diagnosis, engagement in HIV care, and virologic suppression. AIDS, 26(1), 77–86. doi:10.1097/QAD.0b013e32834dcee9</b
   PubMed Web of Science ®Google Scholar
• Donnell, D., Baeten, J. M., Kiarie, J., Thomas, K. K., Stevens, W., Cohen, C. R., … Partners in Prevention HSV/HIV Transmission Study Team. (2010). Heterosexual HIV-1 transmission after initiation of antiretroviral therapy: A prospective cohort analysis. The Lancet, 375, 2092–2098. doi:10.1016/S0140-6736(10)60705-2
   Google Scholar
• Gill, V. S., Lima, V. D., Zhang, W., Wynhoven, B., Yip, B., Hogg, R. S., … Harrigan, P. R. (2010). Improved virological outcomes in British Columbia concomitant with decreasing incidence of HIV type 1 drug resistance detection. Clinical Infectious Diseases, 50(1), 98–105. doi:10.1086/648729
   PubMed Web of Science ®Google Scholar
• Granich, R. M., Gilks, C. F., Dye, C., De Cock, K. M., & Williams, B. G. (2009). Universal voluntary HIV testing with immediate antiretroviral therapy as a strategy for elimination of HIV transmission: A mathematical model. The Lancet, 373(9657), 48–57. doi:10.1016/S0140-6736(08)61697-9
   PubMed Web of Science ®Google Scholar
• Gray, R. H., Wawer, M. J., Brookmeyer, R., Sewankambo, N. K., Serwadda, D., Wabwire-Mangen, F., … Rakai Project, T. (2001). Probability of HIV-1 transmission per coital act in monogamous, heterosexual, HIV-1-discordant couples in Rakai, Uganda. The Lancet, 357, 1149–1153. doi:10.1016/S0140-6736(00)04331-2
   PubMed Web of Science ®Google Scholar
• Greenland, S. (1989). Modeling and variable selection in epidemiologic analysis. American Journal of Public Health, 79, 340–349. doi:10.2105/AJPH.79.3.340
   PubMed Web of Science ®Google Scholar
• Le Moing, V., Chêne, G., Carrieri, M. P., Alioum, A., Brun-Vézinet, F., Piroth, L., … Leport, C. (2002). Predictors of virological rebound in HIV-1-infected patients initiating a protease inhibitor-containing regimen. AIDS, 16(1), 21–29. doi:10.1097/00002030-200201040-00004
   PubMed Web of Science ®Google Scholar
• Montaner, J. S. G., Lima, V. D., Barrios, R., Yip, B., Wood, E., Kerr, T., … Kendall, P. (2010). Association of highly active antiretroviral therapy coverage, population viral load, and yearly new HIV diagnoses in British Columbia, Canada: A population-based study. The Lancet, 376, 532–539.doi:10.1016/S0140-6736(10)60936-1
   PubMed Web of Science ®Google Scholar
• Mugavero, M. J., Amico, K. R., Westfall, A. O., Crane, H. M., Zinski, A., Willig, J. H., … Saag, M. S. (2012). Early retention in HIV care and viral load suppression: Implications for a test and treat approach to HIV prevention. Journal of Acquired Immune Deficiency Syndromes, 59(1), 86–93. doi:10.1097/QAI.0b013e318236f7d2
   PubMed Web of Science ®Google Scholar
• New York City Department of Health and Mental Hygiene. (2011). Recommendation to expand antiretroviral therapy to all persons living with HIV: Frequently asked questions for healthcare providers December 1, 2011. Retrieved November 15, 2012, from http://www.nyc.gov/html/doh/downloads/pdf/ah/nyc-hivart-faq-provider.pdf
   Google Scholar
• Quinn, T. C., Wawer, M. J., Sewankambo, N., Serwadda, D., Li, C., Wabwire-Mangen, F., … Gray, R. H. (2000). Viral load and heterosexual transmission of human immunodeficiency virus type 1. Rakai Project Study Group. The New England Journal of Medicine, 342, 921–929. doi:10.1056/NEJM200003303421303
   PubMed Web of Science ®Google Scholar
• Russell, S. (2010, April 4). City endorses new policy for treatment of H.I.V. New York Times, p. A25a.
   Google Scholar
• State of New York. Public Health Law Article 21 (1983). Public Health Law Article 27-F – HIV and AIDS Information; Public Health Law Article 21, Title III – HIV Reporting and Partner Notification (1998); Code of Administrative Rules and Regulations, Title 10 Part 63 (2000).
   Google Scholar
• The White House. (2010). National HIV/AIDS Strategy for the United States. Washington, DC: Office of National AIDS Policy.
   Google Scholar
• Torian, L. V., & Wiewel, E. W. (2011). Continuity of HIV-related medical care, New York City, 2005-2009: Do patients who initiate care stay in care? AIDS Patient Care and STDs, 25(2), 79–88. doi:10.1089/apc.2010.0151
   PubMed Web of Science ®Google Scholar
• Torian, L. V., & Xia, Q. (2013). Achievement and maintenance of viral suppression in persons newly diagnosed with HIV, New York City, 2006–2009: Using population surveillance data to measure the treatment part of “test and treat”. Journal of Acquired Immune Deficiency Syndromes, 63, 379–386. doi:10.1097/QAI.0b013e3182926b02
   PubMed Web of Science ®Google Scholar
• Udeagu, C. C., Webster, T. R., Bocour, A., Michel, P., & Shepard, C. W. (2013). Lost – or just not following up? Public health effort to re-engage HIV-infected persons lost to follow-up into HIV medical care. AIDS (London, England), 27, 2271–2279. doi:10.1097/QAD.0b013e328362fdde
   Web of Science ®Google Scholar
• Wegzyn, C. M., & Wyles, D. L. (2012). Antiviral drug advances in the treatment of human immunodeficiency virus (HIV) and chronic hepatitis C virus (HCV). Current Opinion in Pharmacology, 12, 556–561. doi:10.1016/j.coph.2012.06.005
   PubMed Web of Science ®Google Scholar